The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-tert-butyl-8-fluoro-2-(3-(hydroxymethyl)-4-(1-methyl-5-(5-(methylsulfonyl)pyridin-2-ylamino)-6-oxo-1,6-dihydropyridin-3-yl)pyridin-2-yl)phthalazin-1(2H)-one ID: ALA4097204
PubChem CID: 71257931
Max Phase: Preclinical
Molecular Formula: C30H29FN6O5S
Molecular Weight: 604.66
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2ccnc(-n3ncc4cc(C(C)(C)C)cc(F)c4c3=O)c2CO)cc(Nc2ccc(S(C)(=O)=O)cn2)c1=O
Standard InChI: InChI=1S/C30H29FN6O5S/c1-30(2,3)19-10-17-13-34-37(29(40)26(17)23(31)12-19)27-22(16-38)21(8-9-32-27)18-11-24(28(39)36(4)15-18)35-25-7-6-20(14-33-25)43(5,41)42/h6-15,38H,16H2,1-5H3,(H,33,35)
Standard InChI Key: DZZJULSJYKYSLJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 47 0 0 0 0 0 0 0 0999 V2000
28.5645 -14.0532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.9773 -13.3475 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.1597 -13.3429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.8195 -10.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8184 -10.9106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5264 -11.3195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2361 -10.9101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2332 -10.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5246 -9.6822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9369 -9.6763 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.6460 -10.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6421 -8.4509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9319 -8.8604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.3512 -8.8590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3472 -9.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0520 -10.0870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7613 -9.6811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7614 -8.8604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0560 -8.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6479 -10.9016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5222 -8.8650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2287 -8.4543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1124 -9.6828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1142 -8.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4105 -8.4563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7004 -8.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6987 -9.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4069 -10.0926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4134 -7.6391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9942 -8.4505 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.9897 -10.0861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9871 -10.9032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2778 -11.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2749 -12.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9818 -12.5329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6932 -12.1221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6926 -11.3070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.0489 -10.9041 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
37.4690 -8.4517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1768 -8.8601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4688 -7.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1727 -8.0357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6873 -13.7599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
10 13 1 0
11 15 1 0
14 12 1 0
12 13 2 0
8 10 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
11 20 2 0
9 21 1 0
21 22 1 0
23 24 2 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
4 23 1 0
25 29 1 0
26 30 2 0
27 31 1 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
16 38 1 0
18 39 1 0
39 40 1 0
39 41 1 0
39 42 1 0
35 2 1 0
2 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 604.66Molecular Weight (Monoisotopic): 604.1904AlogP: 3.62#Rotatable Bonds: 6Polar Surface Area: 149.07Molecular Species: NEUTRALHBA: 11HBD: 2#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.21CX Basic pKa: 1.47CX LogP: 2.36CX LogD: 2.36Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.30Np Likeness Score: -1.14
References 1. Lou Y, Lopez F, Jiang Y, Han X, Brotherton C, Billedeau R, Gabriel S, Gleason S, Goldstein DM, Hilgenkamp R, Kocer B, Orzechowski L, Tan J, Wovkulich P, Wen B, Fry D, Di Lello P, Chen L, Zhang FJ, Fretland J, Nangia A, Yang T, Owens TD.. (2017) Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK)., 27 (3): [PMID:28025004 ] [10.1016/j.bmcl.2016.11.092 ]